Tomas Mimra | Biomedical Engineering | Research Excellence Award

Mr. Tomas Mimra | Biomedical Engineering | Research Excellence Award

VSB – Technical University of Ostrava | Czech Republic

Tomáš Mimra is a biomedical engineer and Ph.D. researcher specializing in technical cybernetics and biomedical engineering, with a strong focus on audiology-oriented medical technologies. He earned his Bachelor’s degree in Biomedical Technology and a Master’s degree in Biomedical Engineering from VŠB – Technical University of Ostrava, where he is currently pursuing a Ph.D. in Technical Cybernetics. Professionally, he serves as a biomedical and clinical engineer at Ostrava University Hospital, combining clinical practice with applied research and academic supervision. His research interests span ENT phoniatrics, cochlear implantation, hearing aids, auditory evoked potentials, biomedical sensors, EEG and fNIRS-based diagnostics, and intelligent signal analysis. He has contributed to international peer-reviewed journals and IEEE-indexed conferences and is actively involved in national biomedical engineering projects.  In addition to research, he has teaching experience across multiple biomedical engineering courses and has supervised several defended bachelor’s theses. His work demonstrates a strong commitment to translational biomedical research, clinical innovation, and the development of advanced diagnostic and training technologies in modern healthcare systems.


View Orcid Profile

Featured Publications


Functional Near-Infrared Spectroscopy (fNIRS) in Objective Audiometry: A Scoping Review and Clinical Perspectives
Tomáš Mimra, Martin Augustynek, Marek Penhaker, Lukáš Klein,
Audiology Research, 2025.

Liudmila Alexandrova | Biology and Life Sciences | Research Excellence Award

Dr. Liudmila Alexandrova | Biology and Life Sciences | Research Excellence Award

EIMB RAS | Russia

Liudmila A. Alexandrova is a senior researcher at the Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, with a distinguished career spanning several decades in molecular biology and medicinal chemistry. She received her education from Lomonosov Moscow State University and completed her postgraduate training at EIMB RAS. An Alexander von Humboldt Foundation, she has gained extensive international research experience through postdoctoral work in Czechoslovakia and Germany. Her scientific contributions include the design and synthesis of biologically active modified nucleosides and nucleotides, with a strong focus on antiviral, antibacterial, and antifungal drug mechanisms. She has authored more than 100 peer-reviewed publications and holds five Russian patents, reflecting a substantial body of documented research output.  She has successfully supervised four PhD dissertations and over 35 diploma theses, while currently mentoring postgraduate researchers. Recipient of two Russian Academy of Sciences awards, her work has significantly advanced the development of novel bacterial and fungal growth inhibitors, establishing her as a respected contributor to biomedical and chemical research with lasting scientific influence.

Citation Metrics (Google Scholar)

2000
1200
600
200
0

Citations
987

Document
89
h-index
19

Citations

Documents

h-index


View Google Scholar Profile

Featured Publications


The synthesis and antituberculosis activity of 5′-nor carbocyclic uracil derivatives
E. Matyugina, A. Khandazhinskaya, L. Chernousova, S. Andreevskaya, Bioorganic & Medicinal Chemistry, 20(22), 6680–6686, 2012. (Citations: 82)


Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides
E.R. Shmalenyuk, L.N. Chernousova, I.L. Karpenko, S.N. Kochetkov, Bioorganic & Medicinal Chemistry, 21(17), 4874–4884, 2013. (Citations: 72)


2′-Deoxynucleoside 5′-triphosphates modified at α-, β- and γ-phosphates as substrates for DNA polymerases
L.A. Alexandrova, A.Y. Skoblov, M.V. Jasko, L.S. Victorova, A.A. Krayevsky, Nucleic Acids Research, 26(3), 778–786, 1998. (Citations: 68)


Oligonucleotide derivatives bearing reactive and stabilizing groups attached to C5 of deoxyuridine
A.S. Levina, D.R. Tabatadse, L.M. Khalimskaya, T.A. Prichodko, G.V. Shishkin, Bioconjugate Chemistry, 4(5), 319–325, 1993. (Citations: 49)


Colorimetric solid-phase minisequencing assay illustrated by detection of alpha 1-antitrypsin Z mutation
L. Harju, T. Weber, L. Alexandrova, M. Lukin, M. Ranki, A. Jalanko, Clinical Chemistry, 39(11), 2282–2287, 1993. (Citations: 47)

Ana Maria Abreu Velez | Medicine and Health Sciences | Best Researcher Award

Dr. Ana Maria Abreu Velez | Medicine and Health Sciences | Best Researcher Award

Georgia Dermatopathology Associates | United States

Dr. Ana María Abreu Vélez, M.D., Ph.D., DSc, is a globally recognized dermatologist, immunohematologist, and biomedical researcher renowned for her leadership in autoimmune orphan diseases and multidisciplinary clinical research. With an impactful scholarly record including 72peer-reviewed publications, an h-index of 14, 659 citations. she has advanced scientific understanding across dermatology, immunology, toxicology, and tropical medicine. Her academic path includes a medical degree, a Doctorate in Science, and multiple postdoctoral fellowships spanning immunohematology, dermatopathology, and translational research. She has served in senior scientific and operational leadership roles, driving innovation, improving surveillance systems, and modernizing data-driven healthcare programs in national and international settings. Her research focuses on autoimmune blistering diseases, environmental toxicants, clinical trials, infectious diseases, and precision diagnostics. Her career includes leading major healthcare programs, enhancing operational efficiency, reducing costs, mentoring multidisciplinary teams, and developing novel scientific frameworks. Widely respected for her analytical rigor and scientific contributions, Dr. Abreu continues to advance global health through research excellence, strategic leadership, and impactful biomedical innovation.

Profiles : Scopus | Orcid

Featured Publications

Abreu Velez, A. M., Ramirez-Posada, M., & Howard, M. S. (2025). Post translational modifications and protein-protein interactome of endemic pemphigus in El Bagre, Colombia: A new variant analysis. Dermatology Practical & Conceptual, 15(3).

Abreu-Velez, A. M., Ramos Muñoz, W., & Howard, M. (2025). Is Tunisian endemic pemphigus foliaceus a real entity or should these cases be reclassified with other autoimmune blistering diseases? Dermatology Practical & Conceptual, 15(2).

Abreu Velez, A. M., Hashimoto, T., Upegui, Y. A., Vélez Arango, J. M., Olarte Aponte, A. M., Vega, J. A., & Howard, M. S. (2025). The pericardium cells junctions are a target for autoantibodies of patients affected by a variant of endemic pemphigus foliaceus in El Bagre and surrounding municipalities in Colombia, South America. Diagnostics, 15(8).

Abreu Velez, A. M., Hashimoto, T., Vélez Arango, J. M., Upegui‐Zapata, Y. A., Upegui‐Quiceño, E., Olarte Aponte, A. M., & Howard, M. S. (2025). New complex cell junctions in and around the intervertebral discs discovered using autoantibodies from patients affected by endemic pemphigus foliaceus in El Bagre, Colombia, South America. International Journal of Dermatology, 64(3).

Abreu Velez, A. M., Ramírez‐Posada, M., & Howard, M. S. (2024). Immunofluorescence findings in a reactivating lichenoid photoallergic chronic dermatitis (actinic reticuloid). Photodermatology, Photoimmunology & Photomedicine, 40(5).

Michel Stéphane Heya | Medicine and Health Sciences | Best Review Paper Award

Assoc. Prof. Dr. Michel Stéphane Heya | Medicine and Health Sciences | Best Review Paper Award

 Universidad Autónoma de Nuevo León | Mexico

Dr. Michel Stéphane Heya is a distinguished researcher and professor specializing in biotechnology, with a Ph.D. from the Institute of Biotechnology, Universidad Autónoma de Nuevo León, Mexico. As a member of the National System of Researchers and Investigators (SNII), he has contributed extensively to the bioprospecting of green alternatives for human health and the development of nanomedicines for controlled pharmacological delivery. His work spans nephroprotective, antifungal, antibacterial, and anticancer applications, employing natural compounds, polymeric nanoparticles, and exosome-based nanocarriers. Dr. Heya has published over 50 scientific articles and book chapters in high-impact journals, accumulating more than 127 citations, with an h-index of 4. His ongoing research focuses on integrating traditional medicine with advanced nanotechnologies to enhance therapeutic efficacy and sustainability. Recognized for his innovative approaches to green nanomedicine, Dr. Heya continues to expand interdisciplinary research, training the next generation of scientists, and promoting environmentally friendly biomedical solutions. His work demonstrates a commitment to advancing health sciences while fostering sustainable and translational research applications.

Profile : Google scholar

Featured Publications

“In Vitro Antifungal Antibacterial Activity of Partitions from Euphorbia tirucalli”

“Diagnóstico de la tinea pedis y tinea unguium en la zona metropolitana de Monterrey, Nuevo León, México”

“Colon Cancer: Overview on Improved Therapeutic Potential of Plant-Based Compounds Using Nanotechnology”

“Plasma Antioxidant Capacity Is Related to Dietary Intake, Body Composition, and Stage of Reproductive Aging in   Women”

“In vitro antifungal activity of polymeric nanoparticles loaded with Euphorbia tirucalli extract”

Manouchehr Fadaee | Medicine and Health Sciences | Best Researcher Award

Dr. Manouchehr Fadaee | Medicine and Health Sciences | Best Researcher Award

Tabriz University of Medical Sciences | Iran

Dr. Manouchehr Fadaee is an accomplished researcher recognized for his contributions to microbiology, immunology, cancer biology, and host–pathogen interactions.  demonstrating consistent productivity and influence in the field. His academic journey is rooted in biomedical sciences, where he advanced his expertise in immunotherapy, cancer progression, gut microbiome, infectious diseases, and exosome-mediated communication. Dr. Fadaee has experience collaborating with international journals, contributing impactful reviews and original research articles in leading platforms such as Journal of Drug Targeting, Cancer Cell International, Cell Communication and Signaling, Breast Cancer Research, and American Journal of Reproductive Immunology. His research interests span exosome-based therapies, postbiotics, gut microbiota, autoimmunity, cancer immunotherapy, and novel antimicrobial strategies. Beyond research, he has actively served as a peer reviewer for journals including Journal of Drug Targeting and Cell Biology International, enhancing the quality of scientific discourse. With several impactful works on immunotherapy and microbial interventions, Dr. Fadaee continues to advance innovative approaches to combat cancer and infectious diseases, making him a promising leader in biomedical research.

Profile : Orcid

Featured Publications

“The Cytotoxic and Immune‐Regulatory Roles of CD8+T Cell‐Derived Exosomes in Cancer: A Systematic Review”

“Gut microbiome and colorectal cancer: From pathogenesis to treatment”

“Potential of Vaginal Microbiota Transplantation (VMT) in Endometritis Management”

“Cyclophosphamide‐Induced Infertility and the Impact of Antioxidants”

“Exosome therapeutics for non-small cell lung cancer tumorigenesis”